Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 1, 2001, Pages 226-233

  Figueroa, D J ^a   Breyer, R M ^a   Defoe, S K ^a   Kargman, S ^a   Daugherty, B L ^a   Waldburger, K ^a   Liu, Q ^a   Clements, M ^a   Zeng, Z ^a   O'Neill, G P ^a   Jones, T R ^a   Lynch, K R ^a   Austin, C P ^a   Evans, J F ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINYLLEUKOTRIENE 1 RECEPTOR; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MESSENGER RNA; MONTELUKAST; PRANLUKAST; UNCLASSIFIED DRUG; ZAFIRLUKAST;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; B LYMPHOCYTE; CONTROLLED STUDY; DRUG ACTIVITY; EOSINOPHIL; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; LUNG ALVEOLUS MACROPHAGE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER;

BLOOD; HUMANS; LEUKOCYTES; LUNG; MEMBRANE PROTEINS; RECEPTORS, LEUKOTRIENE;

EID: 0035152877     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation
2. Leukotrienes and other products of the 5-lipoxygenase pathway: Biochemistry and relation to pathobiology in human diseases
3. 4 synthase. Organization, nucleotide sequence, and chromosomal localization to 5q35
4. Persistent increases in plasma and urinary leukotrienes after acute asthma
5. 4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist
6. Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing
7. Exposure of healthy volunteers to swine house dust increases formation of leukotrienes, prostaglandin D2 and bronchial responsiveness to methacholine
8. Prostanoid and leukotriene receptors: A progress report from the IUPHAR working parties on classification and nomenclature
9. Leukotriene receptors
10. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: A multicenter, randomized, double-blind trial
11. Montelukast for chronic asthma in 6- to 14-year-old children: A randomized, double-blind trial
12. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction
13. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma
14. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: A randomized, controlled trial
15. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-moderate asthma
16. Results of the first U.S. double-blind, placebo-controlled multicenter clinical trial in asthma with pranlukast, a novel leukotriene receptor antagonist
17. 1 receptor
18. Identification, molecular cloning, expression and characterization of a cysteinyl leukotriene receptor
19. A second cysteinyl leukotriene receptor in human lung
20. 4 activates mitogen-activated protein kinase through a protein kinase Cα-Raf-1-dependent pathway in human monocytic leukemia THP-1 cells
21. Cloning, expression, and characterization of the human eosinophil eotaxin receptor
22. Leukotrienes and inflammation
23. CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes
24. Rapid STAT phosphorylation via the B cell receptor: Modulatory role of CD19
25. Regulation of chemoattractant receptor interaction with transducing proteins by organizational control in the plasma membrane of human neutrophils
26. Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells
27. 4 effects on human eosinophil and neutrophil motility in vitro
28. 4 and granulocytic infiltration into asthmatic airways
29. 4 and methacholine on sputum cell differentials in asthma
30. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism
31. Montelukast reduces airway eosinophilic inflammation in asthma: A randomized, controlled trial
32. Cysteinyl leukotrienes partly mediate eotaxin-induced bronchial hyperresponsiveness and eosinophilia in IL-5 transgenic mice
33. On the expression and regulation of 5-lipoxygenase in human lymphocytes
34. + cells in the bronchial mucosa in asthma: Potential airway eosinophil progenitors